Skip to content

Alto Ingredients, Inc. ALTO Granted (in dollars per share)

Granted (in dollars per share) at other companies

Alto Ingredients, Inc. logo
Alto Ingredients, Inc.ALTO
$1.16-39.3%
CHE
ChemedCHE
514.4-8.8%
Norwood Financial logo
Norwood FinancialNWFL
29.6+8.8%
DJT
Trump Media & Technology GroupDJT
$0.00
Southern First Bancshares logo
Southern First BancsharesSFST
$37.09+1.7%
Belden logo
BeldenBDC
$120.25+33.6%

Other financials

Income statement

See full
Revenue$224.7M-0.8%
Gross profit$9.2M+610%
Operating income$2.5M+128%
Net income$4.3M+137%
EPS (diluted)$0.05+131%

Balance sheet

See full
Cash & equivalents$21.6M-20.3%
Total debt$91.3M-30.5%
Total equity$249.9M+16.8%
Total assets$386.3M-4.0%

Cash flow

See full
Operating cash flow$4.2M+123%
CapEx$909.0K+70.9%
Free cash flow$3.3M+118%

Valuation

See full
Market cap$385.88M+342%
Enterprise value$455.51M+138%
P/E13.2×
P/S0.4×+0.3×

Profitability

See full
Gross margin5%
Operating margin2.1%+1.2pp
Net margin3.2%+1.9pp
FCF margin3.4%

Returns & leverage

See full
Return on equity12.6%+7.6pp
Debt / equity0.4×-0.2×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Alto Ingredients, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.

The official record: Alto Ingredients, Inc.’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Ingredients, Inc.'s granted (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alto Ingredients, Inc.'s granted (in dollars per share)?
Alto Ingredients, Inc. (ALTO) reported granted (in dollars per share) of $1.16 in Q4 2025.
What does granted (in dollars per share) mean?
Represents the weighted average grant-date fair value per share for equity instruments, excluding options, granted to employees or directors during the period. This metric reflects the cost basis of equity-based incentives awarded to align stakeholder interests with company performance.